The 6 most recent market catalysts affecting $INTT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 5, 2026
Corporate Catalyst
Bullish
Impact 85
InTest shares are trading higher after the company reported preliminary Q3 orders and revenue at the high end of its guidance range for the third quarter and full year 2026.
This headline is a significant positive catalyst for InTest (INTT) as it demonstrates strong operational performance and demand for their products. Exceeding guidance, especially f…
Oct 5, 2026
Corporate Catalyst
Bullish
Impact 75
InTest Reports Preliminary Q3 Orders Of $48M-$50M, Up 28%-33%; Revenue At High End Of $33M-$35M Guidance
This headline is a significant positive catalyst for InTest (INTT). The substantial increase in preliminary Q3 orders (28%-33% year-over-year) indicates strong demand for their ind…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 92
inTest Q2 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $35.300M Beat $34.968M Estimate
inTest (INTT) announced Q2 adjusted EPS of $0.09, beating the $0.05 consensus by 80%, and sales of $35.300 million, exceeding the $34.968 million estimate. This represents a signif…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 85
InTest shares are trading higher after the company reported preliminary Q2 financial results and raised its FY26 sales guidance above analyst estimates.
InTest announced preliminary Q2 results that likely surpassed market expectations, coupled with a significant upward revision of its FY26 sales guidance. This is a major positive c…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 75
inTest Raises Q2 Prelim Sales Guidance from $32.000M-$34.000M to $35.000M vs $33.013M Est
inTest (INTT) has filed an 8-K to announce a preliminary upward revision to its Q2 sales guidance. The company now expects sales of $35.0 million, up from its previous range and si…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 75
inTest Raises FY2026 Prelim Sales Guidance from $130.000M-$135.000M to $135.000M-$140.000M vs $133.911M Est
inTest (INTT) has raised its preliminary sales guidance for FY2026 from $130M-$135M to $135M-$140M, surpassing the analyst consensus of $133.911M. This upward revision indicates ma…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.